Table 6

Inter-relationships between the clinicopathological characteristics in patients with ER positive primary operable invasive ductal breast cancer (n = 237)
  Size   Grade Involved lymph node PR status HER-2 status Ki-67 status   LVI   MVD Loco-regional treatment Systemic treatment
( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value)
Age (≤50/>50 years) 0.058 0.236 0.495 0.297 0.054 0.641 0.913 0.238 0.261 <0.001
Size (≤20/21-50/>50 mm) 0.033 <0.001 0.879 0.826 0.041 <0.001 0.568 <0.001 0.438
Grade (I/II/III) 0.258 0.753 <0.001 <0.001 <0.001 0.072 0.108 0.627
Involved lymph node (0/1-3/>3) 0.157 0.323 0.035 <0.001 0.607 0.001 0.013
Progesterone –receptor status (PR-/PR+) 0.002 0.340 0.392 0.997 0.256 0.804
HER-2 status (HER-2 -/HER-2+) 0.020 0.119 0.627 0.363 0.603
Ki-67 proliferative activity (Low Ki-67/High Ki-67) 0.049 0.041 0.598 0.289
LVI (Absent/Present) 0.215 0.031 0.255
MVD (tertiles 1, 2, 3) 0.628 0.402
Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy) 0.057

Bold data reflects an association between the two variables.

Mohammed et al.

Mohammed et al. BMC Clinical Pathology 2013 13:31   doi:10.1186/1472-6890-13-31

Open Data